Page last updated: 2024-08-22

camptothecin and prostaglandin d2

camptothecin has been researched along with prostaglandin d2 in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Suzuki, K; Uyeda, M	1
Fujita, M; Koma, H; Nakamura, T; Okamura, N; Yagami, T; Yamamori, M; Yamamoto, Y	1

Other Studies

2 other study(ies) available for camptothecin and prostaglandin d2

Article	Year
Inhibitory properties of antitumor prostaglandins against topoisomerases. Bioscience, biotechnology, and biochemistry, 2002, Volume: 66, Issue:8 Topics: Animals; Antineoplastic Agents; Camptothecin; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; DNA, Superhelical; Doxorubicin; Enzyme Inhibitors; Ethidium; Etoposide; Humans; Mice; Prostaglandin D2; Prostaglandins; Prostaglandins A; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Tumor Cells, Cultured	2002
15-Deoxy-Δ12,14-prostaglandin J2 enhanced the anti-tumor activity of camptothecin against renal cell carcinoma independently of topoisomerase-II and PPARγ pathways. Biochemical and biophysical research communications, 2011, Jul-08, Volume: 410, Issue:3 Topics: Anilides; Antineoplastic Agents; Apoptosis; Camptothecin; Carcinoma, Renal Cell; Caspase 3; Cell Line, Tumor; DNA Topoisomerases, Type II; Drug Synergism; Enzyme Activation; Humans; Kidney Neoplasms; PPAR gamma; Prostaglandin D2	2011

Article

Year

Inhibitory properties of antitumor prostaglandins against topoisomerases.

Bioscience, biotechnology, and biochemistry, 2002, Volume: 66, Issue:8

Topics: Animals; Antineoplastic Agents; Camptothecin; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; DNA, Superhelical; Doxorubicin; Enzyme Inhibitors; Ethidium; Etoposide; Humans; Mice; Prostaglandin D2; Prostaglandins; Prostaglandins A; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Tumor Cells, Cultured

2002

15-Deoxy-Δ12,14-prostaglandin J2 enhanced the anti-tumor activity of camptothecin against renal cell carcinoma independently of topoisomerase-II and PPARγ pathways.

Biochemical and biophysical research communications, 2011, Jul-08, Volume: 410, Issue:3

Topics: Anilides; Antineoplastic Agents; Apoptosis; Camptothecin; Carcinoma, Renal Cell; Caspase 3; Cell Line, Tumor; DNA Topoisomerases, Type II; Drug Synergism; Enzyme Activation; Humans; Kidney Neoplasms; PPAR gamma; Prostaglandin D2

2011